[1] Kneeman JM,Misdraji J,Core Y.Secondary causes of nonalcoholic fatty liver disease .Therap Adv Gastroenterol,2012,5:199-207.
[2] Diehl AM,Day C.Cause,pathogenesis,and treatment of nonalcoholic steatohepatitis. N Engl J Med,2017, 377:2063-2072.
[3] Younossi Z M,Koenig A B,Abdelatif,et al.Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence,incidence,and outcomes.Hepatology,2016,64: 73-84.
[4] ZHU JZ,ZHOU QY,WANG YM,et al.Prevalence of fatty liver disease and the economy in China: A systematic review.WorldJ Gastroenterol,2015,21:5695-5706.
[5] WANG MM,WANG GS,SHEN F,et al.Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated withvirological factors. Dig Dis Sci,2014,59:2571- 2579.
[6] 刘灿雪,李静.非酒精性脂肪肝的研究现状.锦州医科大学学报,2018,39:108-112.
[7] RINELLA ME.Nonalcoholic fatty liver disease: a systematic review.JAMA,2015,313: 2263- 2273.
[8] DIEHL AM,DAY C.Cause,pathogenesis,and treatment of non-alcoholic steatohepatitis.NEngl J Med,2017,377:2063-2073.
[9] Singh S,Kuftinec GN,Sarkar S.Non-alcoholic fatty liver disease in South Asians:a review of the literature.J Clin Transl Hepatol,2017,5:76-81.
[10] 杨蕊旭,范建高.非酒精性脂肪性肝病的流行特征.传染病信息,2018,31:101-111.
[11] Younossi ZM,Stepanova M,Afendy M,et al.Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.Clin Gastroenterol Hepatol,2011,9: 524-530.
[12] 李生鹏,王全楚.非酒精性脂肪性肝病的流行病学进展.胃肠病学和肝病学杂志,2017,26:1085-1087.
[13] Ryu S, Chang Y, Jung HS, et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease.J Hepatol, 2015, 63:1229-1237.
[14] Wei JL,Leung JC,Loong TC, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients:a population study using proton-magnetic resonance spectroscopy.Am J Gastroenterol,2015,110:1306-1314.
[15] Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia.J Hepatol, 2017, 67:862-873. |
